Rare cancer patients could gain better access to targeted drugs through new study
NCT ID NCT04814095
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study follows 30 adults with incurable rare cancers or rare genetic changes who are already taking a Health Canada-approved targeted therapy that is not publicly funded. Researchers will track quality of life, survival, and tumor response over time to generate real-world evidence. The goal is to help health agencies decide whether to fund these treatments for broader use.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this study could help rare cancer patients access funded targeted therapies by providing real-world evidence of their benefits.
What could go wrong
This is a small, early-stage observational study (30 participants) with no control group, so results may not be conclusive or generalizable.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
BC Cancer
RECRUITINGVancouver, British Columbia, V5Z4E6, Canada
Contact Phone: •••-•••-••••